Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew I Milowsky

Showing results (61-70 of 205) with videos related to

Pageof 21
Sort By:
The Oncologist|April 26, 2017
A Systematic Review of Strategies to Prevent Cisplatin-Induced NephrotoxicityDaniel J Crona, Aimee Faso, Tomohiro F Nishijima, et al.
Journal of Oncology Practice|June 23, 2016
Creating a Culture of Safety Within an Institution: Walking the WalkBhishamjit S Chera, Lukasz Mazur, Robert D Adams, et al.
JAMA Oncology|July 17, 2015
Improving Patient Safety in Clinical Oncology: Applying Lessons From Normal Accident TheoryBhishamjit S Chera, Lukasz Mazur, Ian Buchanan, et al.
BJU International|November 14, 2013
Association of hospital volume with conditional 90-day mortality after cystectomy: an analysis of the National Cancer Data BaseMatthew E Nielsen, Katherine Mallin, Mark A Weaver, et al.
Clinical Genitourinary Cancer|May 30, 2006
Clinical utility of radiolabeled monoclonal antibodies in prostate cancerKevin A David, Matthew I Milowsky, Lale Kostakoglu, et al.
The Journal of Urology|November 12, 2003
Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigenDavid M Nanus, Matthew I Milowsky, Lale Kostakoglu, et al.
Clinical Genitourinary Cancer|April 11, 2021
Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder CancerTrevor J Royce, Yuan Liu, Matthew I Milowsky, et al.
Cancer|June 25, 2016
Racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy eraTracy L Rose, Allison M Deal, Bhavani Krishnan, et al.
European Urology|July 22, 2008
Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experienceS Machele Donat, Ahmad Shabsigh, Caroline Savage, et al.
Urologic Oncology|January 9, 2014
Highlights from the first symposium on upper tract urothelial carcinomaSurena F Matin, Shahrokh F Shariat, Matthew I Milowsky, et al.
Pageof 21

Showing results (61-70 of 205) with videos related to

Sort By:
Pageof 21
The Oncologist|April 26, 2017
A Systematic Review of Strategies to Prevent Cisplatin-Induced NephrotoxicityDaniel J Crona, Aimee Faso, Tomohiro F Nishijima, et al.
Journal of Oncology Practice|June 23, 2016
Creating a Culture of Safety Within an Institution: Walking the WalkBhishamjit S Chera, Lukasz Mazur, Robert D Adams, et al.
JAMA Oncology|July 17, 2015
Improving Patient Safety in Clinical Oncology: Applying Lessons From Normal Accident TheoryBhishamjit S Chera, Lukasz Mazur, Ian Buchanan, et al.
BJU International|November 14, 2013
Association of hospital volume with conditional 90-day mortality after cystectomy: an analysis of the National Cancer Data BaseMatthew E Nielsen, Katherine Mallin, Mark A Weaver, et al.
Clinical Genitourinary Cancer|May 30, 2006
Clinical utility of radiolabeled monoclonal antibodies in prostate cancerKevin A David, Matthew I Milowsky, Lale Kostakoglu, et al.
The Journal of Urology|November 12, 2003
Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigenDavid M Nanus, Matthew I Milowsky, Lale Kostakoglu, et al.
Clinical Genitourinary Cancer|April 11, 2021
Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder CancerTrevor J Royce, Yuan Liu, Matthew I Milowsky, et al.
Cancer|June 25, 2016
Racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy eraTracy L Rose, Allison M Deal, Bhavani Krishnan, et al.
European Urology|July 22, 2008
Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experienceS Machele Donat, Ahmad Shabsigh, Caroline Savage, et al.
Urologic Oncology|January 9, 2014
Highlights from the first symposium on upper tract urothelial carcinomaSurena F Matin, Shahrokh F Shariat, Matthew I Milowsky, et al.
Pageof 21